Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2009 1
2011 1
2012 1
2015 1
2016 3
2017 3
2018 2
2019 5
2020 7
2021 5
2022 13
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, Mulatero P. Monticone S, et al. Lancet Diabetes Endocrinol. 2018 Jan;6(1):41-50. doi: 10.1016/S2213-8587(17)30319-4. Epub 2017 Nov 9. Lancet Diabetes Endocrinol. 2018. PMID: 29129575 Review.
We also compared primary aldosteronism subtypes, aldosterone-producing adenoma, and bilateral adrenal hyperplasia. FINDINGS: We identified 31 studies including 3838 patients with primary aldosteronism and 9284 patients with essential hypertension. ...
We also compared primary aldosteronism subtypes, aldosterone-producing adenoma, and bilateral adrenal hyperplasia. FINDINGS: W …
Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review.
Sanga V, Rossitto G, Seccia TM, Rossi GP. Sanga V, et al. Hypertension. 2022 Sep;79(9):1912-1921. doi: 10.1161/HYPERTENSIONAHA.121.18858. Epub 2022 Jun 10. Hypertension. 2022. PMID: 35686552 Free article. Review.
Primary aldosteronism (PA) in pregnancy (PAP) can be a serious condition and is challenging to diagnose. ...
Primary aldosteronism (PA) in pregnancy (PAP) can be a serious condition and is challenging to diagnose. ...
Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis.
Wang A, Wang Y, Liu H, Hu X, Li J, Xu H, Nie Z, Zhang L, Lyu Z. Wang A, et al. Front Endocrinol (Lausanne). 2022 Oct 31;13:1027841. doi: 10.3389/fendo.2022.1027841. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387892 Free PMC article.
PURPOSE: Patients with primary aldosteronism (PA) tend to exhibit a high prevalence of osteoporosis (OP) that may vary by whether PA is unilateral or bilateral, and responsive to PA treatment. ...
PURPOSE: Patients with primary aldosteronism (PA) tend to exhibit a high prevalence of osteoporosis (OP) that may vary by whet …
Primary Aldosteronism and Bone Metabolism: A Systematic Review and Meta-Analysis.
Shi S, Lu C, Tian H, Ren Y, Chen T. Shi S, et al. Front Endocrinol (Lausanne). 2020 Sep 25;11:574151. doi: 10.3389/fendo.2020.574151. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33101208 Free PMC article.
BACKGROUND: Currently, increasing evidence shows that excess aldosterone may have an impact on bone health, and primary aldosteronism (PA) may be a secondary cause of osteoporosis. ...
BACKGROUND: Currently, increasing evidence shows that excess aldosterone may have an impact on bone health, and primary aldosteron …
Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis.
Leung AA, Symonds CJ, Hundemer GL, Ronksley PE, Lorenzetti DL, Pasieka JL, Harvey A, Kline GA. Leung AA, et al. Hypertension. 2022 Aug;79(8):1835-1844. doi: 10.1161/HYPERTENSIONAHA.122.19377. Epub 2022 Jun 2. Hypertension. 2022. PMID: 35652330 Free PMC article.
BACKGROUND: Confirmatory tests are recommended for diagnosing primary aldosteronism, but the supporting evidence is unclear. METHODS: We searched Medline, EMBASE, and the Cochrane Central Register of Controlled Trials. ...CONCLUSIONS: Recommendations for confirmator …
BACKGROUND: Confirmatory tests are recommended for diagnosing primary aldosteronism, but the supporting evidence is unclear. M …
Renal damage in primary aldosteronism: a systematic review and meta-analysis.
Monticone S, Sconfienza E, D'Ascenzo F, Buffolo F, Satoh F, Sechi LA, Veglio F, Mulatero P. Monticone S, et al. J Hypertens. 2020 Jan;38(1):3-12. doi: 10.1097/HJH.0000000000002216. J Hypertens. 2020. PMID: 31385870 Free article.
However, the evidence of an increased risk of renal damage in patients affected by primary aldosteronism remains controversial. We aimed at evaluating the association between primary aldosteronism and renal damage through a meta-analysis. METHODS: We p …
However, the evidence of an increased risk of renal damage in patients affected by primary aldosteronism remains controversial …
Systematic review of surgery and outcomes in patients with primary aldosteronism.
Muth A, Ragnarsson O, Johannsson G, Wängberg B. Muth A, et al. Br J Surg. 2015 Mar;102(4):307-17. doi: 10.1002/bjs.9744. Epub 2015 Jan 20. Br J Surg. 2015. PMID: 25605481 Review.
BACKGROUND: Primary aldosteronism (PA) is the most common cause of secondary hypertension. ...
BACKGROUND: Primary aldosteronism (PA) is the most common cause of secondary hypertension. ...
Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review.
Velema MS, de Nooijer AH, Burgers VWG, Hermus ARMM, Timmers HJLM, Lenders JWM, Husson O, Deinum J. Velema MS, et al. Horm Metab Res. 2017 Dec;49(12):943-950. doi: 10.1055/s-0043-121706. Epub 2017 Dec 4. Horm Metab Res. 2017. PMID: 29202493 Review.
The aim of this review was to determine the impact of primary aldosteronism on health-related quality of life (HRQoL) and mental health. ...To assess HRQoL in these patients more precisely a primary aldosteronism-specific HRQoL questionnaire is require …
The aim of this review was to determine the impact of primary aldosteronism on health-related quality of life (HRQoL) and ment …
Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis.
Chen SY, Chen JY, Huang WC, Puar THK, Chin Kek P, Chueh JS, Lin YH, Wu VC, Study Group T. Chen SY, et al. Eur J Endocrinol. 2022 Nov 22;187(6):S47-S58. doi: 10.1530/EJE-22-0375. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36315466
BACKGROUND: In patients with primary aldosteronism (PA), long-term cardiovascular and mortality outcomes after adrenalectomy vs mineralocorticoid receptor antagonist (MRA) have not been compared yet. ...
BACKGROUND: In patients with primary aldosteronism (PA), long-term cardiovascular and mortality outcomes after adrenalectomy v …
Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis.
Käyser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, Hermus AR, Lenders JW, Deinum J. Käyser SC, et al. J Clin Endocrinol Metab. 2016 Jul;101(7):2826-35. doi: 10.1210/jc.2016-1472. Epub 2016 May 12. J Clin Endocrinol Metab. 2016. PMID: 27172433 Review.
CONTEXT: For health care planning and allocation of resources, realistic estimation of the prevalence of primary aldosteronism is necessary. Reported prevalences of primary aldosteronism are highly variable, possibly due to study heterogeneity. ...CONC …
CONTEXT: For health care planning and allocation of resources, realistic estimation of the prevalence of primary aldosteronism …
50 results